Ali M Al Khathaami, Bayan Al Bdah, Abdulmjeed Alnosair, Abdulkarim Alturki, Rayan Alrebdi, Shorug Alwayili, Sulaiman Alhamzah, Fahad A M AlKhathaami, Nasser Alotaibi
{"title":"不确定来源的年轻人栓塞性卒中(ESUS)的特征和结局:一项回顾性研究。","authors":"Ali M Al Khathaami, Bayan Al Bdah, Abdulmjeed Alnosair, Abdulkarim Alturki, Rayan Alrebdi, Shorug Alwayili, Sulaiman Alhamzah, Fahad A M AlKhathaami, Nasser Alotaibi","doi":"10.1155/2019/4360787","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Embolic stroke of undetermined source (ESUS) in younger adults may have different risk factors compared with ESUS in elderly, and the approach to ESUS in young adults may require new therapies. We aimed to investigate the characteristics and outcomes in younger adults with ESUS at a single centre in Saudi Arabia.</p><p><strong>Patients and methods: </strong>A retrospective study was conducted using the medical records of younger adults with ESUS according to the criteria of the Cryptogenic Stroke/ESUS International Working Group. Younger adults (aged ≤50 years) with ESUS were compared with older patients, on admission and discharge from hospital, using the modified Rankin scale (mRS) and the National Institute of Health Stroke Scale (NIHSS).</p><p><strong>Results: </strong>Among 147 patients with ESUS, 39 (26.5%) were younger adults. Younger adults compared with older adults with ESUS had fewer vascular risk factors, including lower rates of hypertension (43.6% vs. 70.3%; <i>P</i> = 0.004), diabetes (35.9% vs. 57.4%; <i>P</i> = 0.03), and dyslipidaemia (12.8% vs. 28.7%; <i>P</i> = 0.05). There was no significant difference in poor outcome at discharge (defined as mRS > 2), which was observed in 17.9% of younger adults and 28.7% of older adults. Further, there were no significant differences in stroke severity at discharge (NIHSS score ≤5) or median length of stay.</p><p><strong>Discussion: </strong>Although the outcomes of ESUS do not differ between younger and older patients, younger patients have fewer identified risk factors.</p><p><strong>Conclusion: </strong>This study showed that 26.5% of patients with ESUS were aged ≤50 years. Although younger adults with ESUS had fewer risk factors, there were no significant differences in neurologic disability or mortality at discharge, stroke severity, or median length of stay.</p>","PeriodicalId":22054,"journal":{"name":"Stroke Research and Treatment","volume":"2019 ","pages":"4360787"},"PeriodicalIF":1.8000,"publicationDate":"2019-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2019/4360787","citationCount":"2","resultStr":"{\"title\":\"Characteristics and Outcomes of Younger Adults with Embolic Stroke of Undetermined Source (ESUS): A Retrospective Study.\",\"authors\":\"Ali M Al Khathaami, Bayan Al Bdah, Abdulmjeed Alnosair, Abdulkarim Alturki, Rayan Alrebdi, Shorug Alwayili, Sulaiman Alhamzah, Fahad A M AlKhathaami, Nasser Alotaibi\",\"doi\":\"10.1155/2019/4360787\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Embolic stroke of undetermined source (ESUS) in younger adults may have different risk factors compared with ESUS in elderly, and the approach to ESUS in young adults may require new therapies. We aimed to investigate the characteristics and outcomes in younger adults with ESUS at a single centre in Saudi Arabia.</p><p><strong>Patients and methods: </strong>A retrospective study was conducted using the medical records of younger adults with ESUS according to the criteria of the Cryptogenic Stroke/ESUS International Working Group. Younger adults (aged ≤50 years) with ESUS were compared with older patients, on admission and discharge from hospital, using the modified Rankin scale (mRS) and the National Institute of Health Stroke Scale (NIHSS).</p><p><strong>Results: </strong>Among 147 patients with ESUS, 39 (26.5%) were younger adults. Younger adults compared with older adults with ESUS had fewer vascular risk factors, including lower rates of hypertension (43.6% vs. 70.3%; <i>P</i> = 0.004), diabetes (35.9% vs. 57.4%; <i>P</i> = 0.03), and dyslipidaemia (12.8% vs. 28.7%; <i>P</i> = 0.05). There was no significant difference in poor outcome at discharge (defined as mRS > 2), which was observed in 17.9% of younger adults and 28.7% of older adults. Further, there were no significant differences in stroke severity at discharge (NIHSS score ≤5) or median length of stay.</p><p><strong>Discussion: </strong>Although the outcomes of ESUS do not differ between younger and older patients, younger patients have fewer identified risk factors.</p><p><strong>Conclusion: </strong>This study showed that 26.5% of patients with ESUS were aged ≤50 years. Although younger adults with ESUS had fewer risk factors, there were no significant differences in neurologic disability or mortality at discharge, stroke severity, or median length of stay.</p>\",\"PeriodicalId\":22054,\"journal\":{\"name\":\"Stroke Research and Treatment\",\"volume\":\"2019 \",\"pages\":\"4360787\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2019-12-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1155/2019/4360787\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Stroke Research and Treatment\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1155/2019/4360787\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2019/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"PERIPHERAL VASCULAR DISEASE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Stroke Research and Treatment","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2019/4360787","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2019/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 2
摘要
与老年人的ESUS相比,年轻人的不明来源栓塞性卒中(ESUS)可能有不同的危险因素,年轻人的ESUS可能需要新的治疗方法。我们的目的是在沙特阿拉伯的一个中心调查年轻成人ESUS的特征和结果。患者和方法:根据隐源性卒中/ESUS国际工作组的标准,使用年轻ESUS患者的医疗记录进行回顾性研究。采用改良Rankin量表(mRS)和美国国立卫生研究院卒中量表(NIHSS)对ESUS患者(年龄≤50岁)与老年患者在入院和出院时进行比较。结果:147例ESUS患者中,39例(26.5%)为年轻人。与患有ESUS的老年人相比,年轻人的血管危险因素更少,包括高血压发病率更低(43.6%比70.3%;P = 0.004),糖尿病(35.9% vs. 57.4%;P = 0.03),血脂异常(12.8% vs. 28.7%;P = 0.05)。出院时不良预后(定义为mRS > 2)无显著差异,17.9%的年轻人和28.7%的老年人出现不良预后。此外,两组在出院时卒中严重程度(NIHSS评分≤5)或中位住院时间方面无显著差异。讨论:尽管ESUS的结果在年轻患者和老年患者之间没有差异,但年轻患者确定的危险因素较少。结论:26.5%的ESUS患者年龄≤50岁。虽然患有ESUS的年轻成人的危险因素较少,但在神经功能障碍或出院时死亡率、中风严重程度或中位住院时间方面没有显著差异。
Characteristics and Outcomes of Younger Adults with Embolic Stroke of Undetermined Source (ESUS): A Retrospective Study.
Introduction: Embolic stroke of undetermined source (ESUS) in younger adults may have different risk factors compared with ESUS in elderly, and the approach to ESUS in young adults may require new therapies. We aimed to investigate the characteristics and outcomes in younger adults with ESUS at a single centre in Saudi Arabia.
Patients and methods: A retrospective study was conducted using the medical records of younger adults with ESUS according to the criteria of the Cryptogenic Stroke/ESUS International Working Group. Younger adults (aged ≤50 years) with ESUS were compared with older patients, on admission and discharge from hospital, using the modified Rankin scale (mRS) and the National Institute of Health Stroke Scale (NIHSS).
Results: Among 147 patients with ESUS, 39 (26.5%) were younger adults. Younger adults compared with older adults with ESUS had fewer vascular risk factors, including lower rates of hypertension (43.6% vs. 70.3%; P = 0.004), diabetes (35.9% vs. 57.4%; P = 0.03), and dyslipidaemia (12.8% vs. 28.7%; P = 0.05). There was no significant difference in poor outcome at discharge (defined as mRS > 2), which was observed in 17.9% of younger adults and 28.7% of older adults. Further, there were no significant differences in stroke severity at discharge (NIHSS score ≤5) or median length of stay.
Discussion: Although the outcomes of ESUS do not differ between younger and older patients, younger patients have fewer identified risk factors.
Conclusion: This study showed that 26.5% of patients with ESUS were aged ≤50 years. Although younger adults with ESUS had fewer risk factors, there were no significant differences in neurologic disability or mortality at discharge, stroke severity, or median length of stay.